Venture capital firm profile

A specialist venture fund providing capital and operational support to pharma technology companies.
Typically $500K–$2M initial, with follow-on capital reserved. Currency and instrument are not specified.
Typically $500K–$2M initially; currency not specified.
Follow-on capital is reserved; amount not specified.
Founders are invited to email their pitch; a partner reviews every pitch.
These pages were saved for the profile. They have not been mapped to individual claims.
Seed and Series A, typically late seed or early Series A; opportunistic at other stages.
Sources checked
Typically $500K–$2M initial, with follow-on capital reserved. Currency and instrument are not specified.
Sources checked
Specific supporting source not yet mapped.
Typically $500K–$2M initially; currency not specified.
Sources checked
Follow-on capital is reserved; amount not specified.
Sources checked
Disclosed stages: Seed, Series A. Disclosed sectors: Healthcare and life sciences, Software and SaaS. Typically $500K–$2M initial, with follow-on capital reserved. Currency and instrument are not specified.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Loading recent changes…
Founders are invited to email their pitch; a partner reviews every pitch.
Sources checked